| scholarly article | Q13442814 |
| P50 | author | Erwin W. Gelfand | Q81699397 |
| Melvin H Freedman | Q106606530 | ||
| P2093 | author name string | Cohen A | |
| Estrov Z | |||
| Wang XH | |||
| Dubé ID | |||
| Tawa A | |||
| Sulh H | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | deferoxamine | Q419618 |
| acute leukemia | Q976388 | ||
| P304 | page(s) | 757-761 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | In vitro and in vivo effects of deferoxamine in neonatal acute leukemia | |
| P478 | volume | 69 |
| Q55497286 | Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer. |
| Q38892236 | Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines |
| Q26851312 | Cancer cells with irons in the fire |
| Q34869589 | Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1. |
| Q35138336 | Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities. |
| Q36681744 | Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo |
| Q36119319 | Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo |
| Q55447773 | Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo. |
| Q37713467 | Deferoxamine (desferrioxamine). New toxicities for an old drug |
| Q44273660 | Deferoxamine-induced dysplasia-like skeletal abnormalities at radiography and MRI. |
| Q35785106 | Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer |
| Q58593860 | Design, Synthesis, and Biological Evaluation of Novel Polyaminocarboxylate Ligand-Based Theranostic Conjugate for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging |
| Q36557412 | Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types |
| Q36301248 | Effect of microbial siderophores on mammalian non-malignant and malignant cell lines |
| Q34663999 | Effects of iron depletion on CALM-AF10 leukemias. |
| Q44403679 | Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes |
| Q35045012 | Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents |
| Q37138681 | Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention |
| Q40159540 | Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells |
| Q33677592 | Iron and cancer: more ore to be mined |
| Q90098447 | Iron and leukemia: new insights for future treatments |
| Q61796322 | Iron as a Central Player and Promising Target in Cancer Progression |
| Q37177365 | Iron deprivation in cancer--potential therapeutic implications |
| Q46316885 | Isolation, Characterization and Bioactivities of an Extracellular Polysaccharide Produced from Streptomyces sp. MOE6. |
| Q40791618 | Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases |
| Q34576545 | Restoring the secretory function of irradiation-damaged salivary gland by administrating deferoxamine in mice |
| Q37197964 | Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis |
| Q35336409 | Roles of iron in neoplasia. Promotion, prevention, and therapy |
| Q36326247 | Targeting cancer by binding iron: Dissecting cellular signaling pathways |
| Q33426135 | The Eltrombopag antitumor effect on hepatocellular carcinoma |
| Q34580395 | The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity. |
| Q37842957 | The role of iron in tumour cell proliferation |
| Q37427102 | Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging |
| Q73703028 | Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro |
Search more.